Back to Search Start Over

A nerve injury-specific long noncoding RNA promotes neuropathic pain by increasing Ccl2 expression.

Authors :
Du S
Wu S
Feng X
Wang B
Xia S
Liang L
Zhang L
Govindarajalu G
Bunk A
Kadakia F
Mao Q
Guo X
Zhao H
Berkman T
Liu T
Li H
Stillman J
Bekker A
Davidson S
Tao YX
Source :
The Journal of clinical investigation [J Clin Invest] 2022 Jul 01; Vol. 132 (13).
Publication Year :
2022

Abstract

Maladaptive changes of nerve injury-associated genes in dorsal root ganglia (DRGs) are critical for neuropathic pain genesis. Emerging evidence supports the role of long noncoding RNAs (lncRNAs) in regulating gene transcription. Here we identified a conserved lncRNA, named nerve injury-specific lncRNA (NIS-lncRNA) for its upregulation in injured DRGs exclusively in response to nerve injury. This upregulation was triggered by nerve injury-induced increase in DRG ELF1, a transcription factor that bound to the NIS-lncRNA promoter. Blocking this upregulation attenuated nerve injury-induced CCL2 increase in injured DRGs and nociceptive hypersensitivity during the development and maintenance periods of neuropathic pain. Mimicking NIS-lncRNA upregulation elevated CCL2 expression, increased CCL2-mediated excitability in DRG neurons, and produced neuropathic pain symptoms. Mechanistically, NIS-lncRNA recruited more binding of the RNA-interacting protein FUS to the Ccl2 promoter and augmented Ccl2 transcription in injured DRGs. Thus, NIS-lncRNA participates in neuropathic pain likely by promoting FUS-triggered DRG Ccl2 expression and may be a potential target in neuropathic pain management.

Details

Language :
English
ISSN :
1558-8238
Volume :
132
Issue :
13
Database :
MEDLINE
Journal :
The Journal of clinical investigation
Publication Type :
Academic Journal
Accession number :
35775484
Full Text :
https://doi.org/10.1172/JCI153563